Purpose Diverse radionuclide imaging techniques are available for the diagnosis, staging,
and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond their ability to …

Breast cancer diagnosed during pregnancy is a rare occurrence at present; however, in
recent years a trend towards delayed childbirth is generating an increase in its incidence …

Nuclear medicine procedures are generally avoided during pregnancy out of concern for the
radiation dose to the fetus. However, for clinical reasons, radiopharmaceuticals must …

The fetal absorbed dose from 18F-FDG administration to the mother is an essential piece of
information when considering the use of PET to stage cancers during pregnancy. However …

Many clinical conditions require radiological diagnostic exams based on the emission of
different kinds of energy and the use of contrast agents, such as computerized tomography …

Radiopharmaceutical dose estimates to the fetus have been based for many years on the
reported placental crossover data and dose estimates of Russell et al.(1, 2), which used …

Background. Positron emission tomography (PET) has proven clinical utility both in the initial
and relapse staging phase, but this technique is controversial during pregnancy. The …

Current standard values of fetal dosimetry deriving from 18F-FDG injection in pregnant
women are estimated from animal data. The present communication offers a revision of fetal …

The number of nuclear medicine examinations performed worldwide has been steadily
increasing over the last few years. By consequence, an ever increasing number of pregnant …

This article discusses issues regarding administration of radiopharmaceuticals to pregnant
women. Standardized dose estimates and possible biological effects on the unborn child are …